68 Ga-FAPI-04 PET/CT Imaging for Assessing Renal Tubulointerstitial Fibrosis in Lupus Nephritis
Journal of Nuclear Medicine · 2025
DOI: 10.2967/jnumed.124.268643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2025. Verfasst von Shuyi Yu und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Hauptthemen laut MEDLINE: Lupus Nephritis, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
The objective of this study was to evaluate the feasibility of using 68Ga-labeled fibroblast activation protein inhibitor-04 (68Ga-FAPI-04) PET/CT imaging as a molecular tracer and noninvasive tool for assessing active renal tubulointerstitial fibrosis in patients with lupus nephritis (LN).
Methods
The study included 29 LN patients who underwent 68Ga-FAPI-04 PET/CT scanning to quantify 68Ga-FAPI-04 uptake. Renal biopsies were performed within a week of scanning. Renal fibrosis levels in biopsy samples were assessed by Masson staining. Immunofluorescence analysis identified the expression of fibroblast activation protein (FAP), E-cadherin, and α-smooth muscle actin in the renal biopsy specimens. FAP expression of healthy controls, LN patients, and patients with minimal change of disease at the messenger RNA level and its association with interferon levels were explored using microarray data from the Gene Expression Omnibus database. Additionally, quantitative polymerase chain reaction and Western blot analyses quantified FAP messenger RNA and protein expression in renal tubular epithelial cells (RTEC) after stimulation with interferon-α in vitro.
Results
The study revealed significantly increased renal 68Ga-FAPI-04 uptake in LN patients (n = 29) compared with healthy controls (n = 26). Normalized renal 68Ga-FAPI-04 uptake positively correlated with disease duration, creatinine levels, chronicity index, and renal tubulointerstitial fibrosis levels. Patients with a chronicity index exceeding 4, indicative of a poorer prognosis, showed markedly higher renal 68Ga-FAPI-04 uptake. FAP expression was predominantly localized in RTEC, where increased FAP expression corresponded to reduced E-cadherin expression. Gene set enrichment analysis of GSE112943 and GSE60861 datasets showed positive enrichment of type I interferon signaling gene sets (P < 0.01). Correlation analysis of interferon-α and interferon-γ pathways with FAP expression in these datasets was significant (P < 0.01). In vitro experiments, with interferon-α-stimulated RTEC showed elevated FAP expression.
Conclusion
This study demonstrates the feasibility of using 68Ga-FAPI-04 PET/CT imaging for noninvasive assessment of active lupus renal tubulointerstitial fibrosis. Elevated FAP expression in LN is primarily expressed by RTEC and contributes to the development of interstitial fibrosis. Type I interferon appears to induce FAP expression. These findings provide insights into the molecular mechanisms underlying renal tubulointerstitial fibrosis in LN and offer a valuable tool for assessing kidney status in lupus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Department of Rheumatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Rheumatology, First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, China.
- Department of Pathology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Department of Rheumatology and Immunology, Ganzhou People's Hospital, Ganzhou, China.
Zitieren
APA
Yu, S., Yang, Z., Ding, Z., Jia, Y., Wan, L., Li, L., Lv, J., Pan, H., Qian, J., Wei, X., Yang, Y., Zan, Y., Teng, J., Li, B., Yang, C., Xu, J., Xue, L., Shi, H., & Zhang, M. (2025). 68 Ga-FAPI-04 PET/CT Imaging for Assessing Renal Tubulointerstitial Fibrosis in Lupus Nephritis. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.268643
Vancouver
Yu S, Yang Z, Ding Z, Jia Y, Wan L, Li L, et al. 68 Ga-FAPI-04 PET/CT Imaging for Assessing Renal Tubulointerstitial Fibrosis in Lupus Nephritis. Journal of Nuclear Medicine. 2025. doi:10.2967/jnumed.124.268643
BibTeX
@article{Yu2025,
author = {Yu, Shuyi and Yang, Zhixia and Ding, Zetao and Jia, Yingqi and Wan, Liyan and Li, Lei and Lv, Jing and Pan, Haoyu and Qian, Jinyi and Wei, Xiaohan and Yang, Yue and Zan, Yunlong and Teng, Jialin and Li, Biao and Yang, Chengde and Xu, Jing and Xue, Luan and Shi, Hui and Zhang, Min},
title = {68 Ga-FAPI-04 PET/CT Imaging for Assessing Renal Tubulointerstitial Fibrosis in Lupus Nephritis},
journal = {Journal of Nuclear Medicine},
year = {2025},
doi = {10.2967/jnumed.124.268643}
}
EUVIMED